Back to today’s briefing

Story perspectives

New Trials Aim to Combat Treatment-Resistant Depression

3/21/2025

48 5

Summary

Story summary

Almost half of patients with major depressive disorder face treatment-resistant depression (TRD), resulting in deteriorating health and increased unemployment. A Birmingham study underscores the urgent need for tailored care, as existing treatments often leave both patients and providers feeling disheartened. Innovative trials, such as ketamine and Sooma 2GEN, seek to break this cycle of despair.

1 of 1

Story summary

Almost half of patients with major depressive disorder face treatment-resistant depression (TRD), resulting in deteriorating health and increased unemployment. A Birmingham study underscores the urgent need for tailored care, as existing treatments often leave both patients and providers feeling disheartened. Innovative trials, such as ketamine and Sooma 2GEN, seek to break this cycle of despair.